Why Epizyme Stock Is Falling This Week

Shares of biotech Epizyme (NASDAQ: EPZM) have been a bit sickly this week, following the departure of one of its top executives. As of Thursday's market close, the stock was down nearly 13% from the start of the week.

The outgoing executive is CFO Paolo Tombesi, whom Epizyme announced is stepping down from his post effective Friday, July 16. The company wrote without elaboration in a regulatory document filed on Monday that he is to "pursue other business opportunities."

Image source: Getty Images.

Source Fool.com